|
Greer BE, Swensen RE, Gray HJ. Surgery for ovarian cancer: rationale and guidelines. JNCCN. in press.
Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, Goff BA. An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol. 2008;109(1):53-8.
Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol. 2008 May;109(2):215-9.
Gray HJ. Primary management of early stage cervical cancer (IA1-1B) and appropriate selection of adjuvant therapy. J Natl Compr Canc Netw. 2008;6(1):47-52.
Galic V, Willner J, Wollan M, Garg R, Garcia R, Goff BA, Gray HJ, Swisher E. Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas. Genes Chromosomes Cancer. 2007;46(3):239-47.
Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma. Gynecol Oncol. 2006;103(3):793-6.
Goodell V, Salazar L, Urban N, Drescher CW, Gray HJ, Swensen RE, McIntosh MW, Disis ML. Antibody immunity to oncogenic proteins is a prognostic indicator in ovarian cancer. J Clinic Oncol. 2006;24(5):762-8.
Dardarian TS, Gray HJ, Morgan MA, Rubin SC, Randall TC. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol. 2006;101(1):140-2.
Kim SH, Srinivas SK, Rubin SC, Freedman LJ, Gray HJ. Delayed hemorrhage following cervical conization due to severe Factor IX deficiency. Obstet Gynecol. 2004;104(5):1189-92.
|